| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |